OrbiMed Capital GP VII LLC - Insider Non-Derivative Transactions at Passage BIO, Inc. (PASG) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Apr 17, 2025, OrbiMed Capital GP VII LLC's relationship to Passage BIO, Inc. (PASG) is TenPercentOwner, and currently has 6,885,572 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other PASG insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

OrbiMed Capital GP VII LLC - Insider Non-Derivative Transactions of PASG Common Stock

OrbiMed Capital GP VII LLC - Insider Non-Derivative Transactions at PASG

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Apr 18, 2025	Sell -- (Common Stock)	77090	0.33	6885572
Apr 17, 2025	Sell -- (Common Stock)	61638	0.33	6962662
Apr 16, 2025	Sell -- (Common Stock)	10326	0.38	7024300
Jan 9, 2025	Sell -- (Common Stock)	75007	0.68	7257845
Jan 8, 2025	Sell -- (Common Stock)	52536	0.71	7332852
Jan 7, 2025	Sell -- (Common Stock)	19481	0.77	7385388
Dec 21, 2024	Sell -- (Common Stock)	230321	0.6	7404869
Dec 7, 2024	Sell -- (Common Stock)	20903	0.82	7697466
Dec 5, 2024	Sell -- (Common Stock)	76200	0.79	7718369
Sep 19, 2024	Sell -- (Common Stock)	25631	0.73	7833869
Sep 18, 2024	Sell -- (Common Stock)	111400	0.73	7859500
Sep 17, 2024	Sell -- (Common Stock)	63100	0.74	7970900